|
|
Clinical effect of microecologics Bifid Triple Viable Capsules on the adjuvant treatment of senile pneumonia |
GUO Qingchun ZHANG Jiegen ZHANG Shuo SHI Na YANG Yan |
Department of Respiratory Critical Care Medicine, Zhuozhou City Hospital, Hebei Province, Zhuozhou 072750, China |
|
|
Abstract Objective To explore the clinical effects of microecologics Bifid Triple Viable Capsules in the adjuvant treatment of senile pneumonia. Methods The clinical data of 160 senile patients with pneumonia in Department of Respiratory Medicine of Zhuozhou City Hospital from September 2016 to October 2017 were retrospectively analyzed. Patients who were only given conventional anti-infective treatment were included in control group (80 cases). On this basis, patients who were given microecologics adjuvant therapy were included in observation group (80 cases). Serum biochemical parameters [procalcitonin (PCT), diamine oxidase (DAO), endotoxin] and cellular immune markers [CD3+, CD4+/CD8+, natural killer (NK) cell] were compared between the two groups before treatment and after 2 weeks of treatment. And the remission of clinical symptoms/signs and occurrence of adverse drug reactions were analyzed in the two groups after 2 weeks of treatment. Results After 2 weeks of treatment, the serum levels of PCT, DAO and endotoxin were significantly lower than those before treatment, and the levels in observation group were significantly lower than those in control group at the same time (P < 0.05). The CD3+ levels in the two groups were not significantly different from those before treatment, and there was no statistically significant difference between the two groups (P > 0.05). The levels of CD4+/CD8+ and NK cell in the two groups were significantly higher than those before treatment, and the levels in observation group were significantly higher than those in control group at the same time (P < 0.05). The remission times of clinical symptoms/signs in observation group were significantly lower than those in control group (P < 0.05). Within 2 weeks of treatment, the incidence rates of diarrhea, nausea and vomiting and abdominal distension in observation group were significantly lower than those in control group (P < 0.05). There were no significant differences in the incidence rates of dizziness headache and itching rash between the two groups (P > 0.05). Conclusion Microecologics for senile pneumonia can effectively enhance the anti-infective treatment effects, and reduce the gastrointestinal adverse reactions caused by antibiotics, and it is beneficial to the prognosis and rehabilitation of patients.
|
|
|
|
|
[1] 褚月娇,韩莹莹,黄婷婷,等.老年与中青年患者产超广谱β-内酰胺酶肺炎克雷伯菌的分布及耐药性对比分析[J].新乡医学院学报,2017,34(9):803-807.
[2] 郭霞,喻昌利,安庆丽,等.老年重症肺炎患者病原学分布及预后危险因素分析[J].广东医学,2016,37(6):873-875.
[3] 付麒,王彤.老年人口腔机会致病菌——肺炎的危险因素[J].临床肺科杂志,2015,20(11):2106-2108,2113.
[4] Li W,Ding C,Yin S. Aging increases the expression of lung CINCs and MCP-1 in senile patients with pneumonia [J]. Oncotarget,2017,8(65):604-609.
[5] 李振祎.老年性肺炎的诊治分析[J].实用心脑肺血管病杂志,2013,21(6):106-107.
[6] 范建,范贤明.老年肺炎的研究进展[J].中国老年学杂志,2016,36(15):3859-3861.
[7] 王定淼,陈琳,陈勇,等.早期应用复合乳酸菌预防呼吸机相关肺炎的临床疗效及对炎症因子的影响研究[J].临床肺科杂志,2015,20(9):1645-1648.
[8] 中华医学会呼吸病学分会.中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志,2016, 39(4):241-242.
[9] 姜轶飞,杨猛,莫伟强.PCT及hs-CRP在评估老年社区获得性肺炎严重程度中的应用价值[J].中国医药导报,2017,14(2):110-113.
[10] 杨朵,胡梅,李莉,等.C-反应蛋白及降钙素原在血流细菌感染诊断中的应用价值[J].中华医院感染学杂志,2013,23(22):5632-5634.
[11] 周甘平,林春燕.动态监测降钙素原在老年重症肺炎的诊断和优化抗感染治疗中作用概述[J].中国药师,2015, 18(6):1007-1010.
[12] 侯玥,宫平,杨羽,等.血清二胺氧化酶测定的临床应用进展[J].中国实验诊断学,2015,45(11):1985-1986.
[13] 周华,张启杰.炎症性肠病的肠道屏障功能研究[J].内科理论与实践,2015,10(5):381-383.
[14] 宋歌,吕月涛,狄林林,等.免疫肠内营养对重症肺炎病人肠黏膜屏障及免疫功能的影响[J].肠外与肠内营养,2017,24(2):86-89.
[15] 陶梅梅,王洪武,周云芝,等.老年重症和非重症细菌性肺炎淋巴细胞亚群的差异分析[J].国际呼吸杂志,2017, 37(24):1847-1850.
[16] 王志勇,王爱中,徐雯.老年肺炎患者免疫状态初探[J].临床肺科杂志,2013,18(10):1781-1783.
[17] 王珂,黄孝天.肠道菌群调控机体免疫功能的研究进展[J].细胞与分子免疫学杂志,2018,34(2):186-190.
[18] 杨泽冉,辛毅,侯洁,等.肠道菌群失调及其相关疾病研究进展[J].山东医药,2016,56(1):99-101.
[19] 邓芝云,冯强生,宋月娟.我院2012~2015年住院患者肠道菌群失调及其临床诊断分析[J].西北国防医学杂志,2015,36(10):660-663.
[20] 于洪志,吴琦.肠道菌群与肺部疾病关系的研究进展[J].天津医药,2017,45(6):668-672. |
|
|
|